Compile Data Set for Download or QSAR
Report error Found 32 Enz. Inhib. hit(s) with all data for entry = 13010
TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750572(US20250195518, Example 1)
Affinity DataIC50: 3nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750585(US20250195518, Example 24)
Affinity DataIC50: 3nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750594(US20250195518, Example 55)
Affinity DataIC50: 3nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750577(US20250195518, Example 6)
Affinity DataIC50: 3nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750584(US20250195518, Example 19)
Affinity DataIC50: 4nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750576(US20250195518, Example 4)
Affinity DataIC50: 5nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750597(US20250195518, Example 128)
Affinity DataIC50: 5nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750605(US20250195518, Example 255)
Affinity DataIC50: 7nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750588(US20250195518, Example 40)
Affinity DataIC50: 7nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750591(US20250195518, Example 46)
Affinity DataIC50: 10nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750578(US20250195518, Example 7)
Affinity DataIC50: 11nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750581(US20250195518, Example 15)
Affinity DataIC50: 12nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750579(US20250195518, Example 9)
Affinity DataIC50: 13nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750604(US20250195518, Example 254)
Affinity DataIC50: 14nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750603(US20250195518, Example 204)
Affinity DataIC50: 14nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750602(US20250195518, Example 196)
Affinity DataIC50: 14nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750601(US20250195518, Example 173)
Affinity DataIC50: 14nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750600(US20250195518, Example 150)
Affinity DataIC50: 14nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750595(US20250195518, Example 80)
Affinity DataIC50: 17nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750574(US20250195518, Example 3)
Affinity DataIC50: 21nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750598(US20250195518, Example 143)
Affinity DataIC50: 24nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750582(US20250195518, Example 17)
Affinity DataIC50: 27nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750599(US20250195518, Example 144)
Affinity DataIC50: 41nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750593(US20250195518, Example 54)
Affinity DataIC50: 41nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750583(US20250195518, Example 18)
Affinity DataIC50: 45nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750587(US20250195518, Example 39)
Affinity DataIC50: 71nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750592(US20250195518, Example 50)
Affinity DataIC50: 74nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750596(US20250195518, Example 95)
Affinity DataIC50: 144nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750580(US20250195518, Example 11)
Affinity DataIC50: 171nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750590(US20250195518, Example 42)
Affinity DataIC50: 200nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750586(US20250195518, Example 27)
Affinity DataIC50: 225nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetHematopoietic prostaglandin D synthase(Human)
Japan Tobacco

US Patent
LigandPNGBDBM750589(US20250195518, Example 41)
Affinity DataIC50: 374nMAssay Description:The H-PGDS binding inhibitory activity of the test compound was measured by AlphaLISA antagonistic assay. A specific protocol is as follows. In an A...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent